Verapamil Supplier-Buyer Network — Trade Flow Analysis

Name: Verapamil Supplier-Buyer Trade Network Dataset — 135+ Indian Exporters, 11+ Importers, 69+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Verapamil supplier network, Verapamil buyers, pharmaceutical export India, Verapamil trade data

TransData Nexus

Verapamil

India Pharmaceutical Trade Intelligence

$110.6M135 Suppliers69 CountriesHS 30049072

ExportsIndia → UNITED STATES84.9%India → FRANCE14.0%

ImportsGERMANY → India$170.5K UNITED STATES → India$129.0K

#1 Supplier: CADILA PHARMACEUTICALS #1 Buyer: LIFESCIENCE LOGISTICS

Who Supplies Verapamil? Top Manufacturers & Buyers 2026 — CADILA PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1CADILA PHARMACEUTICALS LIMITED

CADILA PHARMACEUTICALS LIMITED is the first-largest Verapamil exporter from India, with a market share of 59.4% and a total export value of $65.7M across 50 shipments. Their average shipment value of $1.3M is above the market average of $89.5K, suggesting premium or bulk contract pricing.

CADILA PHARMACEUTICALS LIMITED serves 2 named buyers in our database. LIFESCIENCE LOGISTICS is the dominant customer, accounting for 94.8% of this supplier's tracked business. Top customers include:

• LIFESCIENCE LOGISTICS — $62.2M across 47 shipments (94.8% of this supplier's total exports)

• LIFESCIENCE LOGISTICS — $3.4M across 3 shipments (5.2% of this supplier's total exports)

Key Insight: CADILA PHARMACEUTICALS LIMITED's per-shipment value of $1.3M is 1368% above the market average of $89.5K, consistent with large-order contracts or value-added formulations.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Verapamil exporter from India, with a market share of 12.8% and a total export value of $14.2M across 96 shipments. Their average shipment value of $147.6K is above the market average of $89.5K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. CSP VIATRIS SANTE AT CSP- LABO is the dominant customer, accounting for 50.6% of this supplier's tracked business. Top customers include:

• CSP VIATRIS SANTE AT CSP- LABO — $7.2M across 49 shipments (50.6% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LABO — $5.0M across 34 shipments (35.2% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC., — $843.4K across 6 shipments (6.0% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LABO — $633.1K across 4 shipments (4.5% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LABO — $533.7K across 4 shipments (3.8% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $147.6K is 65% above the market average of $89.5K, consistent with large-order contracts or value-added formulations.

3ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the third-largest Verapamil exporter from India, with a market share of 8.1% and a total export value of $9.0M across 42 shipments. Their average shipment value of $214.2K is above the market average of $89.5K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $9.0M across 42 shipments (100.0% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $214.2K is 139% above the market average of $89.5K, consistent with large-order contracts or value-added formulations.

4GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fourth-largest Verapamil exporter from India, with a market share of 4.9% and a total export value of $5.5M across 181 shipments. Their average shipment value of $30.2K is below the market average of $89.5K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GLENMARK PHARMACEUTICALS INC USA — $2.3M across 75 shipments (41.2% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $1.8M across 60 shipments (33.4% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $621.9K across 21 shipments (11.4% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $465.0K across 15 shipments (8.5% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $306.3K across 10 shipments (5.6% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (181 shipments) at a per-shipment value of $30.2K, indicating a broad distribution network with many smaller, regular orders.

5MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Verapamil exporter from India, with a market share of 0.8% and a total export value of $831.2K across 16 shipments. Their average shipment value of $51.9K is below the market average of $89.5K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 3 named buyers in our database. CARDINAL 3PL is the dominant customer, accounting for 96.6% of this supplier's tracked business. Top customers include:

• CARDINAL 3PL — $803.2K across 15 shipments (96.6% of this supplier's total exports)

• COIMPORTEX SERVICIOS — $14.1K across 0 shipments (1.7% of this supplier's total exports)

• COIMPORTEX SERVICIOS — $13.9K across 0 shipments (1.7% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (16 shipments) at a per-shipment value of $51.9K, indicating a broad distribution network with many smaller, regular orders.

6CAPLIN STERILES LIMITED

CAPLIN STERILES LIMITED is the fifth-largest Verapamil exporter from India, with a market share of 0.5% and a total export value of $503.3K across 24 shipments. Their average shipment value of $21.0K is below the market average of $89.5K, reflecting a high-volume, competitive pricing strategy.

CAPLIN STERILES LIMITED serves 5 named buyers in our database. BAXTER HEALTHCARE CORPORATION is the dominant customer, accounting for 76.5% of this supplier's tracked business. Top customers include:

• BAXTER HEALTHCARE CORPORATION — $384.9K across 18 shipments (76.5% of this supplier's total exports)

• ALTERNAVIDA SA DE CV — $64.7K across 3 shipments (12.8% of this supplier's total exports)

• COMERCIALIZADORA PHA — $38.9K across 2 shipments (7.7% of this supplier's total exports)

• ALTERNAVIDA SA DE CV — $14.6K across 1 shipments (2.9% of this supplier's total exports)

• BIOTEC BIOLOGICA IND — $223 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: CAPLIN STERILES LIMITED operates with high shipment frequency (24 shipments) at a per-shipment value of $21.0K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Verapamil imports from India, with a total trade value of $93.9M across 343 shipments — representing a 84.9% share of all Verapamil exports. The average shipment value of $273.8K is above the global average of $89.5K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.

Named Verapamil importers in United States: LIFESCIENCE LOGISTICS. is the largest buyer, accounting for 67.4% ($63.3M) of this market's total imports.

• LIFESCIENCE LOGISTICS. — $63.3M (67.4% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES — $9.9M (10.5% of United States's total)

• GLENMARK PHARMACEUTICALS INC., USA — $5.1M (5.5% of United States's total)

Key Insight: United States's per-shipment average of $273.8K (206% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Verapamil imports from India.

Primary Market

Secondary Market

2France

France ranks as the second-largest destination for Verapamil imports from India, with a total trade value of $15.4M across 41 shipments — representing a 14.0% share of all Verapamil exports. The average shipment value of $376.6K is above the global average of $89.5K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Verapamil importers in France: CSP VIATRIS SANTE AT CSP-LAB is the largest buyer, accounting for 46.4% ($7.2M) of this market's total imports.

• CSP VIATRIS SANTE AT CSP-LAB — $7.2M (46.4% of France's total)

• CSP VIATRIS SANTE AT CSP- LAB, — $5.1M (33.3% of France's total)

• CSP VIATRIS SANTE AT CSP- LABO, — $633.1K (4.1% of France's total)

Key Insight: France's per-shipment average of $376.6K (321% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Verapamil imports from India.

Primary Market

Secondary Market

3Mexico

Mexico ranks as the third-largest destination for Verapamil imports from India, with a total trade value of $251.0K across 0 shipments — representing a 0.2% share of all Verapamil exports. The average shipment value of $251.0K is above the global average of $89.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Mexico's per-shipment average of $251.0K (181% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Verapamil imports from India.

Primary Market

Secondary Market

4Netherlands

Netherlands ranks as the fourth-largest destination for Verapamil imports from India, with a total trade value of $212.5K across 0 shipments — representing a 0.2% share of all Verapamil exports. The average shipment value of $212.5K is above the global average of $89.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Netherlands's per-shipment average of $212.5K (137% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Verapamil imports from India.

Primary Market

Secondary Market

5Panama

Panama ranks as the fifth-largest destination for Verapamil imports from India, with a total trade value of $133.8K across 0 shipments — representing a 0.1% share of all Verapamil exports. The average shipment value of $133.8K is above the global average of $89.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Panama's per-shipment average of $133.8K (50% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Panama is a key market for Verapamil imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Verapamil.
2.Flow Mapping: 135 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,236 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 69 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,236 Verified Shipments

135 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Verapamil

Verapamil

Who Supplies Verapamil? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Verapamil? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Verapamil Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CADILA PHARMACEUTICALS LIMITED

2MYLAN LABORATORIES LIMITED

3ZYDUS LIFESCIENCES LIMITED

4GLENMARK PHARMACEUTICALS LIMITED

5MICRO LABS LIMITED

6CAPLIN STERILES LIMITED

From Indian Factories to Global Pharmacies — How Verapamil Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Verapamil Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2France

3Mexico

4Netherlands

5Panama

People Also Ask — Verapamil Supplier & Trade Network

Verapamil Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology